Skip to main content
. Author manuscript; available in PMC: 2023 Nov 28.
Published in final edited form as: Hepatology. 2021 Aug;74(2):961–972. doi: 10.1002/hep.31783

FIG. 1.

FIG. 1.

Overview of eligible and enrolled patients. A total of 280 patients with ALF and ALI were screened for the study and 76 were enrolled. The analysis population included 62 patients with available 13C-MBT results and 21-day outcome, of whom 56 had a day 1 or day 2 13C-MBT test result for efficacy analysis.